Harris C A, Henttu P, Parker M G, Sumpter J P
Department of Biology and Biochemistry, Brunel University, Uxbridge, Middlesex, United Kingdom.
Environ Health Perspect. 1997 Aug;105(8):802-11. doi: 10.1289/ehp.97105802.
A large number of phthalate esters were screened for estrogenic activity using a recombinant yeast screen. a selection of these was also tested for mitogenic effect on estrogen-responsive human breast cancer cells. A small number of the commercially available phthalates tested showed extremely weak estrogenic activity. The relative potencies of these descended in the order butyl benzyl phthalate (BBP) > dibutyl phthalate (DBP) > diisobutyl phthalate (DIBP) > diethyl phthalate (DEP) > diisiononyl phthalate (DINP). Potencies ranged from approximately 1 x 10(6) to 5 x 10(7) times less than 17beta-estradiol. The phthalates that were estrogenic in the yeast screen were also mitogenic on the human breast cancer cells. Di(2-ethylhexyl) phthalate (DEHP) showed no estrogenic activity in these in vitro assays. A number of metabolites were tested, including mono-butyl phthalate, mono-benzyl phthalate, mono-ethylhexyl phthalate, mon-n-octyl phthalate; all were wound to be inactive. One of the phthalates, ditridecyl phthalate (DTDP), produced inconsistent results; one sample was weakly estrogenic, whereas another, obtained from a different source, was inactive. analysis by gel chromatography-mass spectometry showed that the preparation exhibiting estrogenic activity contained 0.5% of the ortho-isomer of bisphenol A. It is likely that the presence of this antioxidant in the phthalate standard was responsible for the generation of a dose-response curve--which was not observed with an alternative sample that had not been supplemented with o,p'-bisphenol A--in the yeast screen; hence, DTDP is probably not weakly estrogenic. The activities of simple mixtures of BBP, DBP, and 17beta-estradiol were assessed in the yeast screen. No synergism was observed, although the activities of the mixtures were approximately additive. In summary, a small number of phthalates are weakly estrogenic in vitro. No data has yet been published on whether these are also estrogenic in vitro. No data has yet been published on whether these are also estrogenic in vivo; this will require tests using different classes of vertebrates and different routes of exposure.
使用重组酵母筛选法对大量邻苯二甲酸酯进行了雌激素活性筛选。还对其中一部分进行了对雌激素反应性人乳腺癌细胞的促有丝分裂作用测试。所测试的少数市售邻苯二甲酸酯显示出极弱的雌激素活性。这些物质的相对效力顺序为邻苯二甲酸丁苄酯(BBP)>邻苯二甲酸二丁酯(DBP)>邻苯二甲酸二异丁酯(DIBP)>邻苯二甲酸二乙酯(DEP)>邻苯二甲酸二异壬酯(DINP)。效力比17β-雌二醇低约1×10⁶至5×10⁷倍。在酵母筛选中具有雌激素活性的邻苯二甲酸酯对人乳腺癌细胞也有促有丝分裂作用。邻苯二甲酸二(2-乙基己基)酯(DEHP)在这些体外试验中未显示出雌激素活性。测试了多种代谢物,包括邻苯二甲酸单丁酯、邻苯二甲酸单苄酯、邻苯二甲酸单乙基己酯、邻苯二甲酸单正辛酯;结果均显示无活性。其中一种邻苯二甲酸酯,邻苯二甲酸二正十三烷基酯(DTDP),产生了不一致的结果;一个样品具有弱雌激素活性,而另一个来自不同来源的样品则无活性。凝胶色谱-质谱分析表明,表现出雌激素活性的制剂含有0.5%的双酚A邻位异构体。邻苯二甲酸酯标准品中这种抗氧化剂的存在可能是在酵母筛选中产生剂量反应曲线的原因——而在未添加邻,对'-双酚A的替代样品中未观察到该曲线;因此,DTDP可能并非弱雌激素性。在酵母筛选中评估了BBP、DBP和17β-雌二醇简单混合物的活性。未观察到协同作用,尽管混合物的活性大致呈加和性。总之,少数邻苯二甲酸酯在体外具有弱雌激素活性。关于这些物质在体内是否也具有雌激素活性,尚未有数据发表;这将需要使用不同类别的脊椎动物和不同暴露途径进行测试。